Observational Study: Non-Invasive Testing for Diabetic Foot Ulcer Healing
This study is looking at a device called SnapshotNIR (Kent Imaging) to see how well it can predict wound healing, flap survival, and how high an amputation might need to be in people with diabetic foot ulcers. The SnapshotNIR device measures oxygen levels in the skin without touching it. Researchers want to see if these measurements can help predict how wounds will heal over three years. You might be able to join if you are 18-89 years old, have diabetes, and have moderate to severe diabetic foot ulcers or infections. The study is currently unclear on its recruitment status, but plans to enroll up to 700 participants.
- Study design
- This is an observational study with no specified phase, meaning participants will receive standard care while researchers collect data. Up to 700 people are planned to be enrolled.
- What's involved
- If you have a diabetic foot ulcer, your lower extremity will be imaged before, during (if possible), and after surgeries, and monthly for up to six months or until the wound heals. If you are a healthy volunteer, you will have one-time imaging and data collection.
- Compensation
- Not stated in the trial record.
- Follow-up
- For participants with diabetic foot ulcers, data will be collected for up to three years to evaluate wound healing.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Non-Invasive Testing to Evaluate Wound Healing in Diabetes
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Andrew P Crisologo, DPM · PRINCIPAL_INVESTIGATOR · University of Texas Southwestern Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Evaluating the effectiveness of SnapshotNIR device to measure perfusion to predict wound healing, flap survival and amputation level healing. The device will report the oxygen saturation, oxyhemoglobin and deoxyhemoglobin levels in superficial tissue.Three years
To evaluate the effectiveness of the Kent instrument to measure perfusion to predict wound healing, flap survival and amputation level healing.